![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/33 | |
A61K 47/10 | |||
A61K 47/32 | |||
A61P 11/00 |
(11) | Number of the document | 2021797 |
(13) | Kind of document | T |
(96) | European patent application number | 07762162.1 |
Date of filing the European patent application | 2007-05-14 | |
(97) | Date of publication of the European application | 2009-02-11 |
(45) | Date of publication and mention of the grant of the patent | 2011-11-23 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2007/068857 |
Date | 2007-05-14 |
(87) | Number | WO 2007/134279 |
Date | 2007-11-22 |
(30) | Number | Date | Country code |
799795 P | 2006-05-12 | US |
(72) |
YOUNG, Christopher, R., US
ROWE, Charles, William, US
|
(73) |
Vertex Pharmaceuticals, Inc.,
130 Waverly Street, Cambridge, MA 02139,
US
|
(54) | COMPOSITIONS OF N-Ý2,4-BIS(1,1-DIMETHYLETHYL)-5-HYDROXYPHENYL¨-1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXAMIDE |
COMPOSITIONS OF N-Ý2,4-BIS(1,1-DIMETHYLETHYL)-5-HYDROXYPHENYL¨-1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXAMIDE |